Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
about
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingCase-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotypeClonal immune responses of Mycobacterium-specific γδ T cells in tuberculous and non-tuberculous tissues during M. tuberculosis infection.Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer.Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from PolandObesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer.Mutation Screening of BRCA Genes in 10 Iranian Males with Breast Cancer.Correlation of the BACH1 Pro919Ser polymorphism with breast cancer risk: A literature-based meta-analysis and meta-regression analysis.Progression inference for somatic mutations in cancer.Whole-exome sequencing of Finnish hereditary breast cancer families.Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study.Frequency of germline PALB2 mutations among women with epithelial ovarian cancer.Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.Improving performance of multigene panels for genomic analysis of cancer predisposition.DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families.Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.Lack of association between cyclin-dependent kinase inhibitor 1B rs2066827 polymorphism and breast cancer susceptibility.Immunohistochemical expression and mutation study of Prohibitin gene in Indian female breast cancer cases.Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families.High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.Nipple-sparing mastectomy in women at high risk of developing breast cancer.Mutation analysis of PALB2 gene in French breast cancer familiesFinnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer
P2860
Q24632270-53C069F1-8F19-48E7-B3A5-F85396908005Q33677756-7F8A1E73-AFCF-4813-8C1C-5D7189DF96C5Q33829340-15A984B9-2796-4D57-85F8-937EAE163DB0Q34154610-26DB7D0E-F35E-4275-A41D-A298B24895EFQ34786007-66BA40F5-60E6-4C79-97E1-C6501A8C5B20Q34964524-688B3922-E67E-456A-A9F4-FB92A9C4F8D6Q35023623-4BB56B36-3910-4854-A582-A988765454B8Q35059075-D251CA16-9F5E-47DC-9FC0-1F09C9C627AEQ36303235-1A11F914-2F20-47E2-B574-0F74816EBA37Q36788273-BD738F56-207C-4AB5-98B8-8A6C1B6ED068Q37079859-11C38144-9C52-4EF1-A97F-B0BEACC39571Q37097543-71165B05-35E2-4FE7-BD7E-7FA4925CDCE7Q37099612-2756F82D-D6A0-44A4-8D32-4B1F2AB503AEQ37207378-115DCC6D-C7F2-40DF-8ADF-BC9A9CBBAD1AQ38793244-98F3CE6D-BFD1-4127-8765-76CA0BDC401CQ38805455-A9EE86D7-0555-4D2E-8D53-16F2D043F801Q39378686-58EE01BD-B6F7-4443-8A8F-585E6C05FFDEQ40580115-9AFEAFEF-4356-429D-8677-C083B38A1960Q41034563-B12FEA13-C345-4DC6-9FBD-F829B7EBAF7DQ41111172-5A42F9C8-421E-4526-BE74-D85B30DD0C14Q42181679-48C28F41-C20B-46CE-9DFD-F4D81EA653E6Q44058392-7152DD68-4576-47BF-8D7C-6A6737DB0EAEQ45026844-F099C6FF-0788-4993-84BD-16E6A6E6B001Q45068453-6253DFE8-905E-4328-88CA-5A0DA6423599Q45972889-AAEFF732-7DD3-4BAF-8E39-50ACC75CD849Q46632048-EE02464F-4157-493E-9B5D-B1B00ACD8F11Q46765063-B1ACCCC5-3286-4980-929B-16E768F6C52EQ50860074-EACA1528-AE94-48D5-B156-8C3316F67B85Q51257152-BFA99299-B34C-4F71-B523-BA087FFAACC3Q55226968-1E6088FD-9D3C-434F-88C9-6381E31503FBQ55603054-546FEF96-1FAA-4D2E-B229-857F87F089AEQ56697958-C993AFBE-D7ED-4ECA-87F6-3308B0220C0CQ57305889-525B03D0-EA34-44C2-8840-82D1682E790A
P2860
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@ast
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@en
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@en-gb
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@nl
type
label
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@ast
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@en
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@en-gb
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@nl
prefLabel
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@ast
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@en
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@en-gb
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@nl
P2093
P2860
P3181
P356
P1476
Screening for BRCA1, BRCA2, CH ...... /or ovarian cancer individuals
@en
P2093
Aleksandra Bebel
Kirsi M Kuusisto
Satu-Leena Sallinen
P2860
P2888
P3181
P356
10.1186/BCR2832
P407
P577
2011-01-01T00:00:00Z
P5875
P6179
1051600659